Our study aimed to evaluate the predictive value of serum ceruloplasmin in patients with ischemic and nonischemic cardiomyopathies, and assess the association between CP levels and the extent of heart failure, CP levels and other parameters in both ischemic and nonischemic cardiomyopathy patients. This evidence concerns the gene CP and cardiomyopathy.